These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994 [TBL] [Abstract][Full Text] [Related]
3. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943 [TBL] [Abstract][Full Text] [Related]
4. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758 [TBL] [Abstract][Full Text] [Related]
5. Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women. Nellemann B; Gormsen LC; Sørensen LP; Christiansen JS; Nielsen S Obesity (Silver Spring); 2012 Jan; 20(1):57-64. PubMed ID: 21959346 [TBL] [Abstract][Full Text] [Related]
6. Central role of the adipocyte in the metabolic syndrome. Bergman RN; Van Citters GW; Mittelman SD; Dea MK; Hamilton-Wessler M; Kim SP; Ellmerer M J Investig Med; 2001 Jan; 49(1):119-26. PubMed ID: 11217141 [TBL] [Abstract][Full Text] [Related]
7. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan M; Girard J Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411 [TBL] [Abstract][Full Text] [Related]
8. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Raz I; Eldor R; Cernea S; Shafrir E Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, hyperinsulinemia, and cancer. Hsu IR; Kim SP; Kabir M; Bergman RN Am J Clin Nutr; 2007 Sep; 86(3):s867-71. PubMed ID: 18265480 [TBL] [Abstract][Full Text] [Related]
10. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance. Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383 [TBL] [Abstract][Full Text] [Related]
11. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Jensen MD Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():20S-24S. PubMed ID: 16642959 [TBL] [Abstract][Full Text] [Related]
12. The regulation of adipose tissue distribution in humans. Björntorp P Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455 [TBL] [Abstract][Full Text] [Related]
13. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Cnop M; Landchild MJ; Vidal J; Havel PJ; Knowles NG; Carr DR; Wang F; Hull RL; Boyko EJ; Retzlaff BM; Walden CE; Knopp RH; Kahn SE Diabetes; 2002 Apr; 51(4):1005-15. PubMed ID: 11916919 [TBL] [Abstract][Full Text] [Related]
14. Extreme insulin resistance of the central adipose depot in vivo. Mittelman SD; Van Citters GW; Kirkman EL; Bergman RN Diabetes; 2002 Mar; 51(3):755-61. PubMed ID: 11872676 [TBL] [Abstract][Full Text] [Related]